UNSPSC 51351602: Aglepristone

This classification denotes an anti-progestin, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0UT4JLE1CM. European Medicines Agency schedules Aglepristone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05285MIG. Aglepristone generally arises in the molecular formula C29H37NO2.

UNSPSC 51351602 Aglepristone, a Commodity code, covers procurement of the veterinary pharmaceutical agent aglepristone — a progesterone antagonist used primarily for termination of pregnancy in dogs and cats in state and local animal control, shelter, and veterinary clinic operations. State and local governments purchase aglepristone as part of routine animal welfare and reproductive management programs, particularly in municipal animal shelters, county humane societies, and veterinary departments within health or public works agencies that operate animal services. The product is sourced through pharmaceutical distributors and veterinary supply vendors and is typically bundled with other veterinary pharmaceuticals and medical supplies in broader procurement vehicles.

The source material contains no recent state and local contract opportunities posted under this code. Without posted solicitations, the geographic distribution of aglepristone purchasing and the specific issuing bodies most active in this market cannot be characterized from current procurement data.